Evidence that nitric oxide is an endogenous antiangiogenic mediator
Open Access
- 1 March 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 111 (3) , 894-902
- https://doi.org/10.1111/j.1476-5381.1994.tb14822.x
Abstract
1 The involvement of nitric oxide (NO) in the regulation of angiogenesis was examined in the in vivo system of the chorioallantoic membrane (CAM) of the chick embryo and in the matrigel tube formation assay. 2 Sodium nitroprusside (SNP) (0.37–28 nmol/disc), which releases NO spontaneously, caused a dose-dependent inhibition of angiogenesis in the CAM in vivo and reversed completely the angiogenic effects of α-thrombin (6.7 nmol/disc) and the protein kinase C (PKC) activator 4-β-phorbol-12-myristate-13-acetate (PMA) (0.97 nmol/disc). In addition, SNP (28 × 10−6 m) stimulated the release of guanosine 3′-5′-cyclic monophosphate (cyclic GMP) from the CAM in vitro. 3 In the matrigel tube formation assay, an in vitro assay of angiogenesis, both SNP (1–3 × 10−6 m) and the cell permeable cyclic GMP analogue, Br-cGMP (0.3–1.0 × 10−3 m) reduced tube formation. 4 The inhibitors of NO synthase, NG-monomethyl-l-arginine (l-NMMA) (3.8–102 nmol/disc) and NG-nitro-l-arginine methylester (l-NAME) (1.3–34.2 nmol/disc) stimulated angiogenesis in the CAM in vivo, in a dose-dependent fashion. d-NMMA and d-NAME on the other hand had no effect on angiogenesis in this system. 5 l-Arginine (10.9 nmol/disc), although it had a modest antiangiogenic effect by itself, was capable of abolishing the angiogenic effects of l-NMMA (34.2 nmol/disc) and of l-NAME (3.8 nmol/disc). 6 Dexamethasone, an inhibitor of the induction of NO synthase, at 0.2–116.1 nmol/disc, stimulated angiogenesis in the CAM, whereas at 348.4–1161 nmol/disc it inhibited this process. Combination of 38.7 nmol/disc dexamethasone with l-NAME (9.3 nmol/disc) resulted in a potentiation of the angiogenic effect of the former. It appears therefore that both the constitutive and the inducible NO synthase may contribute to the NO-mediated inhibition of angiogenesis. 7 Superoxide dismutase (SOD), which prevents the destruction of NO, at 300 i.u./disc had a modest antiangiogenic effect in the CAM, by itself. In addition, SOD, prevented α-thrombin (6.7 nmol/disc) and PMA (0.97 nmol/disc) from stimulating angiogenesis in the CAM. 8 These results suggest that NO may be an endogenous antiangiogenic molecule of pathophysiological importance.Keywords
This publication has 52 references indexed in Scilit:
- NO•, CO and •OH Endogenous soluble guanylyl cyclase‐activating factorsFEBS Letters, 1992
- Glucocorticoids inhibit the induction of nitric oxide synthase and the related cell damage in adenocarcinoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human plateletsBiochemical and Biophysical Research Communications, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateBiochemistry, 1988
- Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures.The Journal of cell biology, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- The involvement of platelets in non-thrombotic processesTrends in Pharmacological Sciences, 1988
- Neovascular responses induced by cultured aortic endothelial cellsJournal of Cellular Physiology, 1983